Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain

Human Reproduction ◽

10.1093/humrep/dei290 ◽

2005 ◽

Vol 21 (1) ◽

pp. 248-256 ◽

Author(s):

P.G. Crosignani ◽

A. Luciano ◽

A. Ray ◽

A. Bergqvist

Keyword(s):

Medroxyprogesterone Acetate ◽

Leuprolide Acetate ◽

Depot Medroxyprogesterone Acetate

Download Full-text

New low dose depot medroxyprogesterone acetate subcutaneous injection is equivalent to leuprolide acetate for endometriosis-associated pain

Fertility and Sterility ◽

10.1016/j.fertnstert.2004.07.182 ◽

2004 ◽

Vol 82 ◽

pp. S71

Author(s):

D.F. Archer ◽

A. Luciano ◽

S. Carson ◽

G. Vilos

Keyword(s):

Medroxyprogesterone Acetate ◽

Subcutaneous Injection ◽

Low Dose ◽

Leuprolide Acetate ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Faculty Opinions recommendation of Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12635.471339 ◽

2006 ◽

Author(s):

Diana Mansour

Keyword(s):

Medroxyprogesterone Acetate ◽

Subcutaneous Injection ◽

Leuprolide Acetate ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Depot Medroxyprogesterone Acetate Subcutaneous Injection 104 mg/0.65 mL (DMPA-SC 104) is Associated With Fewer Hypoestrogenic Symptoms in Patients With Endometriosis Than Leuprolide Acetate

Fertility and Sterility ◽

10.1016/j.fertnstert.2005.07.479 ◽

2005 ◽

Vol 84 ◽

pp. S191-S192

Author(s):

S.A. Carson ◽

J.K. Jain

Keyword(s):

Medroxyprogesterone Acetate ◽

Subcutaneous Injection ◽

Leuprolide Acetate ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Subcutaneous Depot Medroxyprogesterone Acetate versus Leuprolide Acetate in the Treatment of Endometriosis-Associated Pain

Obstetrical & Gynecological Survey ◽

10.1097/01.ogx.0000216525.26292.36 ◽

2006 ◽

Vol 61 (5) ◽

pp. 321-322

Author(s):

P G. Crosignani ◽

A Luciano ◽

A Ray ◽

A Bergqvist

Keyword(s):

Medroxyprogesterone Acetate ◽

Leuprolide Acetate ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Faculty Opinions recommendation of Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12635.467846 ◽

2006 ◽

Author(s):

Charles Coddington

Keyword(s):

Medroxyprogesterone Acetate ◽

Subcutaneous Injection ◽

Leuprolide Acetate ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain

Fertility and Sterility ◽

10.1016/j.fertnstert.2005.07.1315 ◽

2006 ◽

Vol 85 (2) ◽

pp. 314-325 ◽

Author(s):

William D. Schlaff ◽

Sandra Ann Carson ◽

Anthony Luciano ◽

Doug Ross ◽

Agneta Bergqvist

Keyword(s):

Medroxyprogesterone Acetate ◽

Subcutaneous Injection ◽

Leuprolide Acetate ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Author response for "Bone Mineral Density in Antiretroviral Therapy‐Naïve HIV‐1‐Infected Young Adults using Depot Medroxyprogesterone Acetate or Non‐Hormonal Contraceptives in Uganda"

10.1002/jbm4.10446/v2/response1 ◽

2020 ◽

Author(s):

Flavia Kiweewa Matovu ◽

Martin Nabwana ◽

Noah Kiwanuka ◽

Delia Scholes ◽

Esther Isingel ◽

...

Keyword(s):

Bone Mineral Density ◽

Young Adults ◽

Bone Mineral ◽

Medroxyprogesterone Acetate ◽

Author Response ◽

Mineral Density ◽

Depot Medroxyprogesterone Acetate ◽

Download Full-text

Depot Medroxyprogesterone Acetate in Teens: A Risk for Bone Health?

10.1542/peds.106.5.1137 ◽

2000 ◽

Vol 106 (5) ◽

pp. 1137-1138 ◽

Author(s):

Laura K. Bachrach ◽

Tim Cundy ◽

Susan M. Ott

Keyword(s):

Medroxyprogesterone Acetate ◽

Bone Health ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Faculty Opinions recommendation of Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.30424.496155 ◽

2006 ◽

Author(s):

David Hubacher

Keyword(s):

Bone Mineral Density ◽

Bone Mineral ◽

Medroxyprogesterone Acetate ◽

Mineral Density ◽

Depot Medroxyprogesterone Acetate

Download Full-text

Faculty Opinions recommendation of Bone mineral density in women aged 25-35 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.30424.486922 ◽

2006 ◽

Author(s):

Kate Curtis

Keyword(s):

Bone Mineral Density ◽

Bone Mineral ◽

Medroxyprogesterone Acetate ◽

Mineral Density ◽

Depot Medroxyprogesterone Acetate

Download Full-text